Theme: Ways in restoring vision from thief of sight

Glaucoma 2016

Glaucoma 2016

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Types  and Causes of Glaucoma

It is a condition that causes damage to eye’s optic nerve which could cause loss of vision permanently. One of the major reason of Glaucoma is due to the high intraocular pressure damaging the optic nerve which sends images to the brain. Glaucoma can affect both the eyes, but the extent of damage on each eye can be different.

Related Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences

International Conference and Expo on Cataract Conference and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; American Academy of Ophthalmology Conference October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016; 3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.

Symptoms and Diagnosis of Glaucoma

Usually there are very few or no symptoms of glaucoma. However loss of peripheral or side vision would initially take place and eventually leading to the loss of central vision. Hereby early diagnosis of Glaucoma is very important which can be detected through a comprehensive dilated eye exam.

Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences

7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract Conference and Refractive Surgery August 04-05, 2016 Manchester, UK; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; Future World Ophthalmology Congress of the International Council of Ophthalmology Conference 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016;3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.

Treatments for Glaucoma

Effectiveness of treatment depends upon the extent of glaucoma attack in an individual. Early diagnosis plays a major role in treating Glaucoma. Regular treatments can also treat glaucoma to save the remaining vision, however the damage caused is not irreversible.

Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences

10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract Conference and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016; 3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.

Novel therapeutics ways for treating Glaucoma

The most important discovery in scientific research often come from an investigator with new idea. Discussion and gaining knowledge through various scientists would lead the Innovative research leading to cure with an affirmative result for the wellbeing of the society

Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences

8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA;10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology Conference 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016;3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.

Stem Cell Therapy Replacement for Retinal Ganglion Cells

Glaucoma is disease in the eye characterized by the progressive loss of retinal ganglion cells. Stem cell based therapeutics provide a method for restoration of neurons damaged by retinal disease. With the extensive research in the stem cells and its success rate, stem cells can differentiate into retinal neurons in vitro and in vivo following transplantation for retinal degeneration. With stem cell transplantation therapy which has been shown to preserve retinal integrity and attenuate the loss of retinal ganglion cell function when transplanted by using technology.

Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences

International Conference and Expo on Cataract Conference and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO)4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016;3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.

Retinoblastoma

Retinoblastoma is an eye cancer that begins in the retina — the sensitive lining on the inside of your eye. Retinoblastoma most commonly affects young children, but can rarely occur in adults. A rare form of eye cancer, retinoblastoma is the most common form of cancer affecting the eye in children which may affect one or both the eyes.

Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences

6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract Conference and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology Conference 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; American Academy of Ophthalmology October 15-18, Chicago 2016;World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016; 3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; Nationa lGlaucoma Symposium July 30-August 1, Brewster, MA, 2016.

Conference series LLC invites all participants across the world to join the Global Ophthalmology and Glaucoma Conference which is going to be held during October 13-15 at Kuala Lumpur, Malaysia following the theme of “Ways in restoring vision from thief of sight”. Glaucoma-2016 conference will concentrate on latest and exciting innovations in areas of treating glaucoma, diagnostics and recent technologies towards glaucoma treatment and prevention. Glaucoma-2016 also acts as a platform to exchange information, new interventions and strengthen the collaboration among Ophthalmologists, Researchers, Associate Professors, and Scholars from both academia and ophthalmic Institutes.

Conference series LLC Organizes 300+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Glaucoma is the major cause of blindness worldwide. With extensive research being carried out for early diagnosis and treatment of glaucoma can minimize and prevent optic nerve damage, therefore limiting or preventing vision loss. With the advancements in technology, treatment is highly effective, however damage caused by this disease cannot always be reversed – early detection is a key element to prevent vision loss. This three day event include the major sessions

Eye 2016 market research:

Glaucoma Treatment Market research : This glaucoma treatment market report covers provides data and information on The US and Japan under its country coverage. Glaucoma treatment forms a significant portion of the overall eye care market. The market for glaucoma treatment has grown rapidly in the last decade, based on both increasing number of people with glaucoma and the introduction of new treatments. However, the worldwide glaucoma treatment market is expected to decline that can be attributable to price reduction of drugs due to generic availability of many brands in coming years. For this glaucoma treatment market research, the glaucoma pharmaceuticals are segmented into two classes namely prostaglandins analogues (PGAs) and Non PGAs that include beta blockers, carbonic anhydrase inhibitors and alpha agonists. PGAS are the most widely prescribed drug class for glaucoma with latanoprost (brand name Xalatan) the most commonly prescribed drug.

Glaucoma  Drug Forecast and Market research: Glaucoma is a leading cause of preventable blindness globally. This chronic progressive optic neuropathy causes irreversible vision loss through damage to the optic nerve. There are currently no treatments that can directly prevent this damage, and all commercially available glaucoma therapies focus on lowering elevated intraocular pressure (IOP), a known risk factor for glaucoma development and progression. The launch of fixed-dose combination (FDC) products, which combine drugs from these various classes, will continue to be a source of significant growth in this market. The glaucoma market is about to enter a phase of new growth with the arrival of first-in-class drugs, such as Aerie's Rhopressa, Bausch & Lomb's Vesneo (latanoprost bunod), and Inotek's trabodenoson into the 7MM during the forecast period, which will generate additional growth in the global glaucoma market.

Market Growth of Advertising and Marketing:

Figure : No. of conferences related to eye

Source: Reference  8

Fund Allotment to Eye Treatments and Research:

The treatment market for glaucoma will rise in value from $2.4 billion in 2013 to approximately $3 billion by 2023 across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, UK, and Japan, representing a moderate overall Compound Annual Growth Rate (CAGR) of 2.4%, says research and consulting firm GlobalData.

The company’s latest report* states that growth will be driven by the arrival of innovative first-in-class drugs, such as Rhopressa/Roclatan, Vesneo, and trabodenoson, and the introduction of additional fixed-dose combination (FDC) products, such as Tapcom/Taptiqom and Simbrinza, during the forecast period.

 Importance & Scope:

Overview of glaucoma, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.

– Annualized Glaucoma market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.

– Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the glaucoma therapeutics market.

– Pipeline analysis: focus on the eight late-stage pipeline glaucoma drugs discussing emerging trends as well as overview of earlier phase drugs.

– Analysis of the current and future market competition in the global glaucoma therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Why Kuala Lumpur:

Malaysia’s capital is quickly establishing itself as one of Southeast Asia’s leading study destinations. The rapidly improving reputation of Malaysia’s higher education sector, headed by Universiti Malaya (now ranked 146th in the world) reflects the wider coming to prominence of the country itself on the world stage.

Major Associations around the Globe related to Eye:

American Glaucoma Society

British Columbia Association of Optometrists           

American Glaucoma Society

World Glaucoma Association

International Glaucoma Association

Glaucoma Australia

Glaucoma Research Society of Canada

National Eye Institute - Glaucoma Information in Spanish

Optometric Glaucoma Society

South East Asia Glaucoma Interest Group (SEAGIG)

World Glaucoma Patient Association

American Optometric Association

Asia-Pacific Glaucoma Society (APGS)      

Asia-pacific Association of Cataract and Refractive Surgeon

World Association of Eye Hospitals

International Opticians Association

Major Associations related to Eye in Malaysia:

Association of Malaysian Optometrists (AMO)

Malaysian Association for the Blind

Malaysia Glaucoma Society

Malaysian Pharmaceutical Society

Malaysian Society of Ophthalmology

Malaysian Association for the Blind and Blindness

Association of Vision Science Librarians

Statistical Analysis of Associations:

 

Figure : Statistical Analysis of Eye Associations

Source: Reference-1

Target Audience:

Ophthalmologist, researchers, eye surgeons, physicians, eye care specialists,   professors, scientific community, delegates and students are the main participants for the conference. Business professionals (Directors, presidents, CEO) from eye equipment companies.

Graphical Representation of the Target Audience:

Eye Surgeons/Doctors : 50%

Researcher/ Professors: 30%

Business/ Marketing Eye Equipments : 20 %

Figure 2:Target Audience

Source:Reference-2

Top Universities in Kuala Lumpur:

University of Malaysia

International Islamic University Malaysia

International Medical University

HELP University

UCSI University

University of Kuala Lumpur

Asia e University

Universiti Tun Abdul Razak

Figure: Top Universities in Kuala Lumpur

Source:Reference 3

Top Hospitals for Eye Treatments:

Tun Hussein On National Eye Hospital

JMC Specialist Eye Centre

International Specialist Eye Centre

Optimax Eye Specialist Centre

Eye Laser Correction

Chew Eye Specialist & Surgery

New Hope Medic

Angeline Eye Specialist & Laser Centre

At Sun Time Optometry

USJ Eye Specialist

Mata Clinic & Optometrist

Subspecialist Eye Associates

KL Eye Specialist Centre

Normah Medical Specialist Centre

Eye Specialist Centre Kuching

Stasticial Representation of Top Hospitals for Eye Treatment:

Figure : Hospitals for Eye Treatment

Source:Reference 5

Statistics of future projection of  Marketers, Researchers and Academicians working on Eye and vision:

Figure : People

 

Reference:

 

http://www.prnewswire.com/news-releases/glaucoma-treatment-market-2014-2019-global-trends--opportunities-reviewed-in-new-research-report-277572941.html

 

http://www.prnewswire.com/news-releases/pharmapoint-glaucoma---global-drug-forecast-and-market-analysis-to-2023-300136410.html

 

http://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/glaucoma-treatment-market-value-will-grow-moderately-to-3-billion-by-2023-says-globaldata

 

http://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/glaucoma-treatment-market-value-will-grow-moderately-to-3-billion-by-2023-says-globaldata

Ophthalmology 2015

OMICS International played host to a diverse panel of key members of the Ophthalmology community from research lab, industry, academia and financial investment practices, discussing the future of Ophthalmology specialties. This event was really aimed for examining where the real ophthalmological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Ophthalmology.

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful.

Ophthalmology- 2015 Organizing Committee would like to thank the Moderators of the conference, Dr. Vijaya Juturu, Omni Active Health Technologies Inc., USA, Dr. Emmanuel S Buys, Massachusetts General Hospital, USA and Dr. Yoko Miura, University of Luebeck, Germany for their contributions which resulted in the smooth functioning of the conference.

The conference was initiated with a series of eponymous lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

·         Maria Dolores Pinazo Duran from University of Valencia, Spain

·         Jacob Lorenzo-Morales University of La Laguna, Spain

·         Francisco Javier Carreras from University of Granada, Spain

·         Janardan Kumar from Becker College, USA

Instruction course carried by Dr. Atul Bansal, Consultant Ophthalmologist, University Hospital Coventry & Warwickshire, UK “Customising surgical glaucoma treatment to the patient and their disease”

OMICS 5th International Conference on Clinical & Experimental Ophthalmology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Ophthalmology, International Journal of Ophthalmic Pathology and Biological Systems: Open Access. 


Past Reports  Gallery  

Eye 2015

The International Conference on Eye Disorder and Treatment (Eye-2015) hosted by OMICS Group took place at Double Tree by Hilton Baltimore- BWI Airport, USA during July 13-15, 2015. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals as well as from eminent scientists, talented researchers and young student community. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations highlighting the theme, “Scientific perspectives for a better vision and to pioneer innovations in ocular treatment & care”. Researchers and students who attended from different parts of the world has made the conference one of the most successful and productive events in 2015 from OMICS Group.

The conference was initiated with a warm welcome note from the Honorable guests and Keynote forum session which was sponsored by Visiometrics. The proceedings went through interactive sessions and panel discussions headed by Lyne Racette Indiana University, USA honorable Moderator for the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

Age related cataract: Pathogenesis and possible therapy - Dr. Manuel B DatilesNational Institutes of Health, USA

Quality of vision, what do we need to know? - Dr. Jan BonelVisiometrics, Spain

The innovations and new technologies used in the diagnosis and treatment of glaucoma in Bolivia - Dr. Manuel Jose Justiniano, Bolivian Society of Glaucoma, Bolivia

Evidence-based decisions and real life applications - Dr. Albert S KhouriRutgers New Jersey Medical School, USA

Advances in retinoblastoma - Dr. Arpitha ParthasarathyUS Medical Innovations, USA

Eye-2015 Conference also witnessed symposium by Dr. Arpitha Parthasarathy, US Medical Innovations, USA along with Dr. Mary Beth Aronow, Johns Hopkins University, USA about “Selective ablation of ocular cancer cells and cancer stem cells with cold atmospheric plasma and advances in prognostication for uveal melanoma respectively”.

A workshop session on “Ophthalmic telemedicine and glaucoma management” chaired by Dr. Daniel Valverde, University of Guayaquil, Ecuador and presented by Dr. Albert S Khouri, Rutgers from New Jersey Medical School, USA enlightened the crowd with recent researches.

Also, the conference proceeding was encouraged through the wonderful special session by Dr. Cesar Gomezperalt, Vision Perception, Mexico about “Quality of vision and life perception after automated lamellar keratoplasty for treating moderate to severe keratoconus: Day one to full recovery”.

OMICS Group has taken the privilege of felicitating Eye-2015 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference sponsor appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Eye-2015 Conference. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group “Journal of Clinical and Experimental Ophthalmology” as a special issue.


Past Reports  Gallery  

Ophthalmology-2014

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 4th International Conference on Clinical & Experimental Ophthalmology was held during July 14-16, 2014 in Baltimore, USA

OMICS Group played host to a diverse panel of key members of the Ophthalmology community from research lab, industry, academia and financial investment practices, discussing the future of Ophthalmology specialties. This event was really aimed for examining where the real ophthalmological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Ophthalmology.

Focusing on Cornea and External Eye Disease, Retina and Retinal Disorders, Glaucoma: Visual Field Loss, Neuro-Ophthalmology, Ocular Microbiology and Immunology, Research Trends in Surgical and Medical Ophthalmology,Ophthalmic Research and Drug Development, and Novel Approaches to Ophthalmology Therapeutics as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Ophthalmology-2014 Organizing Committee would like to thank the Moderator of the conference, Dr. Rebecca M. Sappington, Vanderbilt University School of Medicine, USA who contributed a lot for the smooth functioning of this event. We are also thank full to all the speakers who made this event a grand success, our special thanks to Dr. Chris Hekimian, Inventor of the Quantitative Retina Test Grid for exhibiting at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by Chi-Chao Chan from National Institutes of Health, USAand Ashim K Mitra from University of Missouri-Kansas City, USA, Sayon Roy from Boston University School of Medicine, USA, Jayne S. Weiss fromLouisiana State University Health Sciences Center, USA. These talks were of great interest to the general ophthalmologists and were enormously informative.

OMICS 4th International Conference on Clinical & Experimental Ophthalmology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Ophthalmology, International Journal of Ophthalmic Pathology and Biological Systems: Open Access. 


Past Reports  Gallery  

Ophthalmology-2013

The 3rd International Conference on Clinical & Experimental Ophthalmology, hosted by the OMICS Group was successfully held during April 15-17, 2013 in Chicago/Northbrook, USA. Outstanding response and active participation received from the Researchers, Leaders from Pharmaceutical R&D sectors, Government Organizations, and Principal Investigators. And Editorial Board Members of OMICS Group helped in making this meeting an ostentatious success.

Keynote Speakers:

•             Dr. Chi-Chao Chan, National Institutes of Health, USA

•             Dr. Lea Hyvarinen, Technical University of Dortmund, Germany

•             Dr. Christopher Hekimian, dxdt Engineering and Research, USA

•             Dr. Sayon Roy, University of Naples, Italy

A series of invited lectures by Honorable guests and members of the Keynote forum marked the commencement of the event. Keynote session was very prolific to the scientific community and they lifted up solutions and illustrated a way on the theme "Intolerable Disparity in Vision and Novel Therapies"

Scientific sessions established active contribution from researchers and principal investigators, and the Poster presentations were phenomenally excellent with the enthusiastic students and fellow researchers. It established a new prospect and hopes on ongoing projects in field of Ophthalmology.

OMICS Group felicitated all the Organizing Committee Members and Editorial Board Members who enthusiastically participated in the conference and made this meeting a huge success.

OMICS Group on behalf of OCMs and EBMs congratulates all the Best Poster Awardees for their outstanding contribution in the field of Ophthalmology and simultaneously encourage all the participants who tried to put their efforts in poster presentations and wish them success for their future research.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 13-15, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
glaucoma@insightconferences.com
Sponsors / Exhibiting / Advertising.
glaucoma@conferenceseries.com
General Queries.
glaucoma@conferenceseries.com

View Proceedings of Previous Conferences

Eye-2015
Ophthalmology 2014
Ophthalmology 2013
Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.